Tenaya Therapeutics, Inc. ($TNYA)

Feb 25, 26SELLCOLUMN GROUP III GP, LP· 10% owner1,862,545 sh @ $0.56−$1.05M↗

Feb 25, 26SELLCOLUMN GROUP III GP, LP· 10% owner1,649,281 sh @ $0.56−$928K↗

Feb 24, 26SELLCOLUMN GROUP III GP, LP· 10% owner349,212 sh @ $0.62−$215K↗

Feb 24, 26SELLCOLUMN GROUP III GP, LP· 10% owner309,228 sh @ $0.62−$190K↗

Feb 23, 26SELLCOLUMN GROUP III GP, LP· 10% owner162,291 sh @ $0.60−$97K↗

Feb 23, 26SELLCOLUMN GROUP III GP, LP· 10% owner143,709 sh @ $0.60−$86K↗

Feb 20, 26SELLCOLUMN GROUP III GP, LP· 10% owner277,769 sh @ $0.61−$171K↗

Feb 20, 26SELLCOLUMN GROUP III GP, LP· 10% owner245,965 sh @ $0.61−$151K↗

Feb 17, 26SELLAli Faraz· Chief Executive Officer5,851 sh @ $0.64−$4K↗

Feb 17, 26SELLAli Faraz· Chief Executive Officer5,032 sh @ $0.64−$3K↗

Feb 17, 26SELLAli Faraz· Chief Executive Officer3,979 sh @ $0.64−$3K↗

Feb 17, 26SELLHiga Tomohiro· SVP, Finance2,022 sh @ $0.64−$1K↗

Feb 17, 26SELLTingley Whittemore· Chief Medical Officer1,876 sh @ $0.64−$1K↗

Feb 17, 26SELLTingley Whittemore· Chief Medical Officer1,642 sh @ $0.64−$1K↗

Feb 17, 26SELLHiga Tomohiro· SVP, Finance836 sh @ $0.64−$538↗

Feb 17, 26SELLHiga Tomohiro· SVP, Finance611 sh @ $0.64−$393↗

Feb 11, 26SELLCOLUMN GROUP III GP, LP· 10% owner2,151,458 sh @ $0.68−$1.46M↗

Feb 11, 26SELLCOLUMN GROUP III GP, LP· 10% owner1,905,115 sh @ $0.68−$1.30M↗

Feb 10, 26SELLCOLUMN GROUP III GP, LP· 10% owner182,295 sh @ $0.82−$149K↗

$TNYATenaya Therapeutics, Inc.